TEVA PHARMACEUTICAL INDUSTRIES LIMITED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.52 USD | +0.09% |
|
-3.28% | +58.05% |
| 06-25 | Global markets live: UBS, Boeing, AT&T, Rivian, Nvidia, Tesla... |  |
| 06-25 | Teva Pharmaceutical Pays $750 Million to Resolve Tax-Related Litigation | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
Pharmaceuticals
Calendar
2024-08-06
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
16.5
USD
Average target price
18.34
USD
Spread / Average Target
+11.13%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +58.05% | 18.69B | |
| +55.30% | 815B | |
| +45.28% | 654B | |
| -6.67% | 354B | |
| +21.56% | 337B | |
| +10.03% | 302B | |
| +17.71% | 247B | |
| +2.09% | 229B | |
| +12.95% | 219B | |
| +9.52% | 171B |
- Stock Market
- Equities
- TEVA Stock
- News Teva Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Insider Sold Shares Worth $1,352,090, According to a Recent SEC Filing
